Business Description
Apollon Formularies PLC
ISIN : IM00BJ0LRD77
Description
Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.53 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.77 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 39.9 | |||||
3-Year EPS without NRI Growth Rate | 47.7 | |||||
3-Year FCF Growth Rate | 37.9 | |||||
3-Year Book Growth Rate | -67.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 32.17 | |||||
14-Day RSI | 38.13 | |||||
6-1 Month Momentum % | -50 | |||||
12-1 Month Momentum % | -50 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.6 | |||||
Quick Ratio | 0.6 | |||||
Cash Ratio | 0.03 | |||||
Days Sales Outstanding | 5026.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -260.8 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -839.58 | |||||
Net Margin % | -1591.67 | |||||
FCF Margin % | -64.29 | |||||
ROE % | -29.66 | |||||
ROA % | -20.07 | |||||
ROIC % | -13.71 | |||||
3-Year ROIIC % | -86.71 | |||||
ROC (Joel Greenblatt) % | -235.21 | |||||
ROCE % | -15.64 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.03 | |||||
EV-to-EBIT | -2.66 | |||||
EV-to-EBITDA | -2.66 | |||||
EV-to-Revenue | 22.33 | |||||
EV-to-FCF | -34.58 | |||||
Earnings Yield (Greenblatt) % | -37.59 | |||||
FCF Yield % | -2.76 |